By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immunovative Therapies, Ltd. 

P.O. B 974

  Shoham  60850  Israel
Phone: 972-3-9702090 Fax:



Company News
Immunovative Therapies, Ltd. Release: CryoVax : Next Generation Immunotherapy For Metastatic Colorectal Cancer Begins USA Phase IIb Clinical Trial 11/7/2016 11:34:21 AM
Tauriga Sciences Inc. (TAUG) Receives Positive Update From Immunovative Therapies, Ltd. And Expected Start Date For Pivotal Phase 2/3 Breast Cancer Trial 1/3/2014 8:57:25 AM
The Unique Mirror EffectTM Cancer Treatment of Immunovative Therapies, Ltd. 7/22/2013 8:17:18 AM
Immunovative Therapies, Ltd. Introduces a Revolutionary Approach to Cancer Treatment 7/9/2013 9:36:09 AM
Immunovative Inc. Announces Settlement Agreement With Immunovative Therapies, Ltd. 3/4/2013 9:15:51 AM
Immunovative Inc. Discovers Material Information in Connection With Its Lawsuit Against Immunovative Therapies, Ltd. 1/23/2013 10:13:39 AM
Immunovative Inc. Responds to Wrongful Termination Notice of License Agreement and Demands Immediate Return of $3.7 Million Due to Multiple Contractual Breaches by Israeli Based Immunovative Therapies, Ltd. 1/14/2013 9:40:36 AM
Immunovative Inc. Announces the Appointment of Dr. Zivile Katiliene as Director of Regulatory Affairs and Clinical Operations for Immunovative Therapies, Ltd. 8/3/2012 9:48:18 AM
Immunovative Inc. Announces the Appointment of Professor Emmanuel Katsanis, M.D. as Chief Medical Officer, Medical Director and Chairman of the Scientific Advisory Board of Immunovative Therapies, Ltd. 7/25/2012 9:13:01 AM
Immunovative Therapies, Ltd. Announces That Dr. Michael Har-Noy Has Been Invited to Speak at the 5th World Cancer Congress in Beijing, China 5/16/2012 8:31:05 AM